The fiduciary1 playbook.
ERISA1 does not ask whether an investment turned out well. It asks whether your process was prudent at the time of decision. For alternatives, the process burden is real but entirely manageable. It looks like this.
Establish committee capacity
Document that your committee has, or has hired, the expertise to evaluate private-market strategies. The DOL's 2021 supplement1 makes this the threshold question. An independent 3(21) adviser or 3(38) investment manager is the standard answer for most plans.
Update the investment policy statement
Add language covering permitted alternative exposures, maximum allocations, valuation methodology expectations, liquidity requirements, and benchmarking approach. Do this before selecting any product.
Diligence the vehicle, not just the asset class
Evaluate the specific implementation. Look at sleeve caps, liquidity buffer sizing and stress scenarios, gating provisions, valuation cadence and independence, underlying manager access and track record, and total all-in cost versus the incumbent.
Run a rigorous fee analysis
Compare total expense against both the incumbent option and reasonable alternatives. Document why any incremental cost is justified by expected net-of-fee benefit. Fees are the center of gravity in ERISA1 litigation.
Benchmark deliberately
Agree in advance how the option will be judged. Options include a custom blend, a public-markets-plus-premium benchmark, or peer TDF universes. Appraisal smoothing will flatter short-term risk metrics. Your monitoring framework should account for it.
Plan the participant communication
Disclosures should explain, in plain language, what changed inside the default, how valuation and liquidity work, and what it costs. Clear communication is both good practice and good defense.
Document everything, then keep monitoring
Keep minutes, diligence reports, fee comparisons, and rationale memos. Follow with quarterly monitoring and pre-defined triggers for re-evaluation. Triggers include liquidity events, valuation disputes, manager turnover, or persistent underperformance.
QDIA note. Because the realistic delivery vehicle is your target-date default, this is ultimately a QDIA1 decision. It is the highest-stakes selection a committee makes. Treat a private-markets TDF as a full QDIA replacement search, not a product swap.
A one-page committee agenda.
Whether you are exploring or executing, this is the order of operations for a well-run committee meeting on the topic.
Exploration phase
Educational review of the asset class and the vehicle landscape. Review of DOL guidance history and current status. Discussion of committee capacity and adviser scope. Preliminary risk-appetite framing. Decision: proceed to formal evaluation, or not.
Evaluation phase
IPS1 amendment for permitted exposures. Manager and vehicle short-list with diligence memos. Fee analysis versus incumbent. Benchmark framework. Communication draft. Decision: adopt, defer, or reject a specific product.
Implementation phase
Adoption resolution with rationale memo attached. Recordkeeper coordination and blackout planning. Participant disclosure roll-out. First-quarter monitoring cadence set.
Monitoring phase
Quarterly performance and attribution review. Annual fee re-benchmark. Ongoing review of valuation cadence, liquidity stress, and manager changes. Pre-defined watch-list triggers.